New EBE president elected
This article was originally published in SRA
The biotech industry association European Biopharmaceutical Enterprises has elected Marc de Garidel as its new president for a two-year term. Mr de Garidel, vice president south region of Amgen International, takes over the presidency from Genzyme's Dr Carlo Incerti, who will remain on the EBE board as vice president. Mr de Garidel has been on the EBE board since 2006, as vice president and treasurer.